Paul Tudor Jones's CNTA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 121,810 shares of Centessa Pharmaceuticals plc (CNTA) worth $3.05 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in CNTA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 105,925 shares. Largest reduction occurred in Q2 2025, reducing 55,074 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Centessa Pharmaceuticals plc (CNTA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Centessa Pharmaceuticals plc (CNTA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +64,000 | Add 110.71% | 121,810 | $25.01 |
| Q3 2025 | +6,959 | Add 13.69% | 57,810 | $24.25 |
| Q2 2025 | -55,074 | Reduce 51.99% | 50,851 | $13.14 |
| Q1 2025 | +105,925 | New Buy | 105,925 | $14.38 |
| Q3 2021 | -43,079 | Sold Out | 0 | $0.00 |
| Q2 2021 | +43,079 | New Buy | 43,079 | $22.22 |
Paul Tudor Jones's Centessa Pharmaceuticals plc Investment FAQs
Paul Tudor Jones first purchased Centessa Pharmaceuticals plc (CNTA) in Q2 2021, acquiring 43,079 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Centessa Pharmaceuticals plc (CNTA) for 6 quarters since Q2 2021.
Paul Tudor Jones's largest addition to Centessa Pharmaceuticals plc (CNTA) was in Q1 2025, adding 105,925 shares worth $1.52 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 121,810 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $3.05 M.
As of the Q4 2025 filing, Centessa Pharmaceuticals plc (CNTA) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Centessa Pharmaceuticals plc (CNTA) was 121,810 shares, as reported at the end of Q4 2025.